TY - JOUR
T1 - Insight Into Nicotinamide Adenine Dinucleotide Homeostasis as a Targetable Metabolic Pathway in Colorectal Cancer
AU - Colombo, Giorgia
AU - Gelardi, Edoardo Luigi Maria
AU - Balestrero, Federica Carolina
AU - Moro, Marianna
AU - Travelli, Cristina
AU - Genazzani, Armando A.
N1 - Publisher Copyright:
Copyright © 2021 Colombo, Gelardi, Balestrero, Moro, Travelli and Genazzani.
PY - 2021/11/22
Y1 - 2021/11/22
N2 - Tumour cells modify their cellular metabolism with the aim to sustain uncontrolled proliferation. Cancer cells necessitate adequate amounts of NAD and NADPH to support several enzymes that are usually overexpressed and/or overactivated. Nicotinamide adenine dinucleotide (NAD) is an essential cofactor and substrate of several NAD-consuming enzymes, such as PARPs and sirtuins, while NADPH is important in the regulation of the redox status in cells. The present review explores the rationale for targeting the key enzymes that maintain the cellular NAD/NADPH pool in colorectal cancer and the enzymes that consume or use NADP(H).
AB - Tumour cells modify their cellular metabolism with the aim to sustain uncontrolled proliferation. Cancer cells necessitate adequate amounts of NAD and NADPH to support several enzymes that are usually overexpressed and/or overactivated. Nicotinamide adenine dinucleotide (NAD) is an essential cofactor and substrate of several NAD-consuming enzymes, such as PARPs and sirtuins, while NADPH is important in the regulation of the redox status in cells. The present review explores the rationale for targeting the key enzymes that maintain the cellular NAD/NADPH pool in colorectal cancer and the enzymes that consume or use NADP(H).
KW - ALDH = aldehyde dehydrogenase
KW - CD38
KW - NAD
KW - NADPH
KW - NAMPT (nicotinamide phosphoribosyltransferase)
KW - PARP
KW - isocitrate dehydrogenase (IDH)
KW - sirtuins
UR - http://www.scopus.com/inward/record.url?scp=85120679167&partnerID=8YFLogxK
U2 - 10.3389/fphar.2021.758320
DO - 10.3389/fphar.2021.758320
M3 - Review article
SN - 1663-9812
VL - 12
JO - Frontiers in Pharmacology
JF - Frontiers in Pharmacology
M1 - 758320
ER -